Ravicti and The flu - a phase IV clinical study of FDA data

Summary:

The flu is reported as a side effect among people who take Ravicti (glycerol phenylbutyrate), especially for people who are female, 2-9 old, also take Arginine, and have Ammonia increased.

The phase IV clinical study analyzes which people have The flu when taking Ravicti. It is created by eHealthMe based on reports of 1,197 people who have side effects when taking Ravicti from the FDA, and is updated regularly.

What is Ravicti?

Ravicti has active ingredients of glycerol phenylbutyrate. eHealthMe is studying from 1,197 Ravicti users. Check the latest studies of Ravicti.

What is The flu?

The flu (the flu is caused by an influenza virus) is found to be associated with 2,171 drugs and 2,719 conditions by eHealthMe. Check the latest studies of The flu.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 17, 2026

1,197 people reported to have side effects when taking Ravicti.
Among them, 32 people (2.67%) have The flu.

Among these 32 people:

What is the gender of people who have The flu when taking Ravicti? *

female: 65 %
male: 35 %

What is the age of people who have The flu when taking Ravicti? *

What are other drugs people take besides Ravicti? *

What are other side effects people have besides The flu? *

Ammonia Increased: 11 people, 34.38%
Nausea And Vomiting: 10 people, 31.25%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 25.00%
Fever: 6 people, 18.75%
Otitis (ear infection): 6 people, 18.75%
Hypophagia (reduced food intake): 5 people, 15.62%
White Blood Cell Count Decreased: 4 people, 12.50%
Abdominal Distension: 4 people, 12.50%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 12.50%
Weight Increased: 4 people, 12.50%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 9.38%
Ammonia Increased: 3 people, 9.38%
Argininosuccinate Synthetase Deficiency: 2 people, 6.25%
Hyperammonaemia: 1 person, 3.12%
Carbamoyl Phosphate Synthetase Deficiency (metabolic disorder that causes ammonia to accumulate in the blood): 1 person, 3.12%
Arginase Deficiency (inherited disorder that causes the amino acid arginine (a building block of proteins) and ammonia to accumulate gradually in the blood): 1 person, 3.12%
Amino Acid Metabolism Disorder: 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ravicti and have The flu?

- Check whether The flu is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ravicti:

Ravicti (1,197 reports)

The flu treatments and more:

The flu (145,738 reports)

Browse all side effects of Ravicti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with The flu:

The flu (2,171 drugs)

Browse all the conditions that are associated with The flu:

The flu (2,719 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glycerol phenylbutyrate (the active ingredients of Ravicti) and Ravicti (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.